Article
Persistent Cytotoxic Immune Signaling in Anti-VEGF–Treated Neovascular Age-Related Macular Degeneration
2026-04-10
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Purpose</h4> Anti-vascular endothelial growth factor (anti-VEGF) therapy is the standard of care for neovascular age-related macular degeneration (AMD), yet many patients exhibit persistent retinal degeneration, fibrosis, and incomplete therapeutic response. The molecular pathways underlying this incomplete response remain poorly understood. We sought to identify VEGF-independent signaling...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 13893095-caae-511c-9276-c0274a9beff7
- DOI
- 10.64898/2026.04.06.26350115
